Hims vs Hers: One Company, Two GLP-1 Telehealth Brands

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Hims and Hers are the rare comparison where both brands share a corporate parent, which makes the interesting question not who wins but why one company runs two front doors. This PlexusDx Education Hub review examines that structure, then turns to a biological factor the shared infrastructure leaves untouched. Browse all Peptides & GLP-1 education.

Independence statement: PlexusDx has no commercial relationship with Hims, Hers, or Hims & Hers Health. This review contains no affiliate links, no sponsorship, and no referral fees.

Hims and Hers are both operated by Hims & Hers Health, presented as sibling brands with different audiences. Comparing them is less about competing companies and more about how one platform tailors the same telehealth machinery to different users. Below we look at the shared parent, the branding split, the common medication pathway, cost, and the inherited variable neither brand measures. Details reflect public information as of April 2026.

One company, two front doors

Hers and Hims both sit under Hims & Hers Health and run on subscription telehealth. In each case a patient completes a virtual evaluation, a licensed clinician reviews eligibility, and an appropriate prescription follows, either an FDA-approved brand GLP-1 or a compounded semaglutide or tirzepatide from a licensed compounding pharmacy. The two brands maintain separate sites: Hers's official website and Hims's official website.

How the branding splits the audience

The most visible difference is presentation, not plumbing. Hims and Hers use distinct branding, tone, and design aimed at different audiences, while drawing on shared clinical and fulfillment infrastructure. For a GLP-1 seeker, that means the front-end experience may feel different even when the back-end pathway, from clinician review to pharmacy dispensing, is fundamentally alike.

The medication pathway they share

Because both brands sit on the same platform, their GLP-1 pathway is largely common. A prescription can route to a retail pharmacy for a branded product or to a 503A compounding pharmacy for a compounded semaglutide or tirzepatide, with follow-up supporting titration. Differences in specific medication menus or tiers may exist between the two brands, but the underlying structure is shared rather than competing.

The pharmacology under both brands

Whichever door you enter, the drug class is the same. GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, plus the dual GIP/GLP-1 agonist tirzepatide, act on appetite, satiety, and gastric emptying. Branding does not touch pharmacology. The evidence base sits with the compounds: STEP for semaglutide in weight management (New England Journal of Medicine, 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024).

What each brand costs

Each brand publishes its own pricing, which varies by product, subscription tier, and dispensing pathway. Across GLP-1 telehealth as of April 2026, monthly totals commonly range from roughly $200 to $700 or more. Because two brands under one parent may still price differently, and because numbers change, verify current rates on each brand's own page rather than assuming they match.

The variable one platform cannot brand around

No amount of audience-specific branding reads the inherited biology a GLP-1 acts on. A variant in GLP1R, the receptor these compounds target, together with FTO, MC4R (central to satiety and energy balance), and TCF7L2 (linked to glucose handling), maps your baseline metabolic terrain. These pathway-level markers do not predict how a specific compound will perform, but they describe the biology beneath either brand's front door.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before a protocol, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2. Test before you invest.

Not affiliated: PlexusDx has no relationship with Hims, Hers, or Hims & Hers Health and reviewed both brands independently.

Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.

Disclaimer: This article is educational. PlexusDx is not affiliated with Hims or Hers and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Explore the Weight Management Protocols or begin with the Precision Peptide Genetic Test.

Frequently Asked Questions

Are Hims and Hers the same company?

Yes. Both brands are operated by Hims & Hers Health and presented as sibling services aimed at different audiences. They use distinct branding but draw on shared clinical and fulfillment infrastructure. The main differences you will encounter are front-end experience and any brand-specific medication tiers, not the underlying corporate structure.

Does one brand offer better GLP-1 pricing than the other?

Because both sit under one parent, pricing can be similar, but each brand publishes its own rates that may differ by product and tier and change over time. Compare current numbers on each brand's own site at the same commitment level rather than assuming the sibling brands charge identically.

Does the Precision Peptide Genetic Test differ by brand?

No. The test is independent of Hims, Hers, or any telehealth brand and does not predict drug response. It maps pathway-level variants such as FTO and MC4R, and TCF7L2 that describe your baseline metabolic biology, providing context that applies no matter which front door you use.

Where does PlexusDx fit alongside a shared-parent brand?

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols and adds the Precision Peptide Genetic Test for upstream context, mapping FTO, MC4R. That pathway-level genetic layer is what neither Hims nor Hers builds into its shared telehealth platform.

Keep exploring the Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.